Title : Complete remission of membranous nephropathy in a patient with lung adenocarcinoma treated with erlotinib.

Pub. Date : 2020 Apr

PMID : 31730733






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Since an epidermal growth factor receptor mutation was identified by analysis of the exfoliated tumour cells in pleural effusion, erlotinib was administered, without further treatment of the membranous nephropathy. erlotinib epidermal growth factor receptor Homo sapiens
2 WHAT IS NEW AND CONCLUSION: For patients with EGFR-mutation-positive lung adenocarcinoma associated with paraneoplastic membranous nephropathy, erlotinib might serve as a treatment option for both the tumour and the membranous nephropathy. erlotinib epidermal growth factor receptor Homo sapiens